The Biotechnology R&D intensity in France's business sector indicates a steadily increasing trend from 2024 to 2028. The R&D intensity is forecasted to rise from 0.086% in 2024 to 0.094% in 2028, reflecting a positive year-on-year growth rate. The compound annual growth rate (CAGR) over the five-year period is anticipated to be significant, underlining a sustained commitment to biotechnology research and development within the industry.

Future trends to watch for include:

Increased investment in biotechnology startups and collaborations with academic institutions.
Government policies and funding initiatives aimed at bolstering the biotechnology sector.
Technological advancements and innovations that could accelerate research outcomes and commercial applications.
Global market influences and partnerships that may drive further R&D intensity.